Oramed Pharmaceuticals Inc. said Joshua Hexter stepped down as the company's COO and vice president of business development due to personal reasons.
The Israeli company named Mark Hasleton as its new vice president of business development, effective Nov. 15.
Hasleton has served in several leadership and pharmaceutical development roles, including at Teva Pharmaceutical Industries Ltd. and Bristol-Myers Squibb Co.
Israel-based Oramed Pharmaceuticals engages in the research and development of pharmaceutical solutions.
